Cathepsin D gene and the risk of Alzheimer's disease: a population-based study and meta-analysis

Neurobiol Aging. 2011 Sep;32(9):1607-14. doi: 10.1016/j.neurobiolaging.2009.10.011. Epub 2009 Nov 18.

Abstract

Cathepsin D (CTSD) is a gene involved in amyloid precursor protein processing and is considered a candidate for Alzheimer's disease (AD). The aim of the current study was to examine if variation in CTSD increases the risk of AD. We performed a candidate-gene analysis in a population-based cohort study (N=7983), and estimated the effect of CTSD on the risk of AD. Additionally, a large meta-analysis was performed incorporating our data and previously published data. The T-allele of CTSD rs17571 was associated with an increased risk of AD (p-value 0.007) in the Rotterdam Study. This association was predominantly found in APOE ε4 noncarriers. A meta-analysis of previously published data showed a significantly increased risk of AD in carriers of the T-allele of rs17571 (OR 1.22, 95% CI 1.03-1.44), irrespective of APOE ε4 carrier status. This study adds to the evidence that CTSD increases the risk of AD, although the effect size is moderate.

Publication types

  • Meta-Analysis
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / epidemiology*
  • Alzheimer Disease / genetics*
  • Case-Control Studies
  • Cathepsin D / genetics*
  • Cohort Studies
  • Evidence-Based Medicine / trends
  • Female
  • Genetic Predisposition to Disease / epidemiology*
  • Genetic Predisposition to Disease / genetics*
  • Humans
  • Longitudinal Studies
  • Male
  • Polymorphism, Single Nucleotide / genetics
  • Risk Factors

Substances

  • CTSD protein, human
  • Cathepsin D